This issue of Behavioral Health Industry Insights details the impact of deinstitutionalization and the IMD Exclusion on the behavioral healthcare landscape. On April 25, 2016, the CMS issued a long-awaited official rule meaningfully changing the IMD Exclusion provisions in response to access concerns over inpatient psychiatric and substance use disorder services.
Corporate Finance and Restructuring
M&A advisory, restructuring and insolvency, debt advisory, strategic alternatives, transaction diligence and independent financial opinions.
Mergers and Acquisitions (M&A) Advisory
Kroll’s investment banking practice has extensive experience in M&A deal strategy and structuring, capital raising, transaction advisory services and financial sponsor coverage.
Healthcare Investment Banking
Healthcare expertise for middle-market M&A transactions.
Financial Sponsors Group
Dedicated coverage and access to M&A deal-flow for financial sponsors.
Transaction Advisory Services
Kroll’s Transaction Advisory Services platform offers corporate and financial investors with deep accounting and technical expertise, commercial knowledge, industry insight and seamless analytical services throughout the deal continuum.
Kroll is headquartered in New York with offices around the world.
One World Trade Center
285 Fulton Street, 31st Floor
New York NY 10007
Sign up to receive periodic news, reports, and invitations from Kroll.
Our privacy policy describes how your data will be processed.
© 2025 Kroll, LLC. All rights reserved.
Kroll is not affiliated with Kroll Bond Rating Agency,
Kroll OnTrack Inc. or their affiliated businesses. Read more.